Testing effectiveness (Phase 2)Study completedNCT03535168What this trial is testingRepeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough PatientsWho this might be right forCough Bayer 59
Early research (Phase 1)Ended earlyNCT02289482What this trial is testingA Single Dose Pharmacokinetic (PK) and Safety Study of GSK2838232 With and Without Ritonavir (RTV) Conducted in Healthy SubjectsWho this might be right forInfection, Human Immunodeficiency Virus GlaxoSmithKline 20
Early research (Phase 1)WithdrawnNCT06533280What this trial is testingVH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)Who this might be right forHIV Infections ViiV Healthcare
Early research (Phase 1)Looking for participantsNCT07613710What this trial is testingA Trial to Test the Safety and Tolerability of Lu AH69593 in Adults That Are Healthy or Have NarcolepsyWho this might be right forNarcolepsy H. Lundbeck A/S 104
Early research (Phase 1)Study completedNCT02439359What this trial is testingA Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy SubjectsWho this might be right forStaphylococcus Aureus Bloodstream Infections (BSI; Bacteremia) ContraFect 20
Early research (Phase 1)Study completedNCT06092788What this trial is testingSafety, Pharmacokinetics (PK) and Relative Bioavailability of NTP42:KVA4 as a Solid Oral DoseWho this might be right forHealthy ATXA Therapeutics Limited 13
Early research (Phase 1)Study completedNCT01949103What this trial is testingTD-1607 MAD Study in Healthy SubjectsWho this might be right forInfectionsBacterial Infections Theravance Biopharma 48
Early research (Phase 1)Study completedNCT02215759What this trial is testingSafety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 44370 TA Tablets in Healthy Male and Female VolunteersWho this might be right forHealthy Boehringer Ingelheim 34
Early research (Phase 1)Study completedNCT01031186What this trial is testingFirst Time in Human StudyWho this might be right forDepressive Disorder and Anxiety Disorders GlaxoSmithKline 20
Early research (Phase 1)Study completedNCT04142086What this trial is testingDose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in AdultsWho this might be right forYellow Fever (Healthy Volunteers) Sanofi Pasteur, a Sanofi Company 73
Early research (Phase 1)Study completedNCT01638325What this trial is testingInsulin Lispro With BioChaperone Excipient in Healthy ParticipantsWho this might be right forHealthy Participants Adocia 37
Early research (Phase 1)Study completedNCT04213196What this trial is testingSafety, Tolerability and Pharmacokinetics of HSK21542 in Healthy VolunteersWho this might be right forHealthy Volunteers Sichuan Haisco Pharmaceutical Group Co., Ltd 66
Early research (Phase 1)Study completedNCT02253927What this trial is testingDose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy VolunteersWho this might be right forHealthy Boehringer Ingelheim 48
Early research (Phase 1)Study completedNCT00615576What this trial is testingRepeat Dose Study in Male Healthy Volunteer SmokersWho this might be right forPulmonary Disease, Chronic Obstructive GlaxoSmithKline 13
Early research (Phase 1)Study completedNCT01523990What this trial is testingEvaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected PatientsWho this might be right forHealthyHepatitis C, Chronic TaiGen Biotechnology Co., Ltd. 135
Early research (Phase 1)Study completedNCT00958503What this trial is testingEffect of Thiamphenicol on EAAT2 and Other Biomarkers From Nasal Biopsied TissueWho this might be right forHealthy Psyadon Pharma 30
Early research (Phase 1)Looking for participantsNCT04216342What this trial is testingSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy VolunteersWho this might be right forCardiovascular Disease National Heart, Lung, and Blood Institute (NHLBI) 64
Early research (Phase 1)Study completedNCT02291991What this trial is testingStudy to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GX-E2 in Healthy SubjectsWho this might be right forHealthy Genexine, Inc. 10
Early research (Phase 1)Not Yet RecruitingNCT07545590What this trial is testingEltrekibart (LY3041658) in Healthy ParticipantsWho this might be right forHealthy Eli Lilly and Company 60
Early research (Phase 1)Study completedNCT04526496What this trial is testingSafety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian VolunteersWho this might be right forHealthy Sichuan Haisco Pharmaceutical Group Co., Ltd 75